Found 11 matching trials
A Prospective Study of Response-adapted Low-dose Radiotherapy Combined With Orelabrutinib for Localized Mucosa-associated Lymphoid Tissue Extranodal Marginal Zone Lymphoma PHASE2 Multi center, randomized, controlled, prospective clinical trial to explore...
Show More Location
Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Learn More & Join Trial
The Treatment of Ocular Adnexal Extranodal Marginal Zone B-cell Lymphoma by Orelabrutinib and Radiotherapy PHASE2 Extranodal marginal zone B-cell lymphoma (EMZL) is the most common lymphoma...
Show More Location
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Learn More & Join Trial
Ultra-low-dose Radiation Therapy Followed by Orelabrutinib as First-line Treatment for Stage Ⅰ-Ⅱ MALT Lymphoma PHASE2 This is a prospective, multicenter Phase 2 clinical trial named the MALT-RO...
Show More Location
No. 1, East Banshan Road , Gongshu District
Learn More & Join Trial
Orelabrutinib Followed by Response-adapted Ultra-low Dose 4Gy Radiation as First-line Treatment of MALT Lymphoma PHASE2 Investigate the efficacy and safety of Orelabrutinib followed by response-a...
Show More Status
Active Not Recruiting
Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
A Study of MIL62 Combined With Orelabrutinib for the Treatment of R/R CD20+B Cell Lymphoma PHASE1 Dose escalation and expansion phase I/IIa clinical study of recombinant hum...
Show More Location
The First Affiliated Hospital of Bengbu Medical College
Learn More & Join Trial
DDI Study of Orelabrutinib PHASE1 This is a phase I, single-center, open-label, fixed-sequence clinical study...
Show More Location
The First Affiliated Hospital of Soochow University
Learn More & Join Trial
Orelabrutinib Plus Low-Dose Radiotherapy Or Rituximab For Ocular Adnexal MALT Lymphoma PHASE2 This is a phase II, prospective clinical study to evaluate the efficacy and...
Show More Status
Active Not Recruiting
Location
2ndAffiliated Hospital, School of Medicine, Zhejiang University, China
Learn More & Join Trial
Evaluating Different Doses of Orelabrutinib in MCL PHASE2 This is A Randomized,Open-label, Multicenter, Phase II Trial Evaluating Two...
Show More Location
The First Affiliated Hospital of Bengbu Medical College
Learn More & Join Trial
CD20 Monoclonal Antibody-Based First-Line Therapy in Treatment-Naive Marginal Zone B-Cell Lymphoma N/A This is a multicenter, real-world study on first-line CD20 monoclonal antib...
Show More Location
Multiple Locations
Learn More & Join Trial
Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Systemic Lupus Erythematosus PHASE2 This is a phase IIb, randomized, double-blind, placebo-controlled, multicen...
Show More Location
The first affiliated hospital of bengbu medical college
Learn More & Join Trial